Curriculum-Based Online and Live Activities


Course Director
Ghassan Abou-Alfa, MD, MBA
Memorial Sloan Kettering Cancer Center
New York, New York

Curriculum Description

The expanding treatment landscape for HCC provides challenges to clinicians to effectively incorporate new agents into personalized care for their patients. Utilizing a web-based educational activity and onsite sessions at US medical facilities, this curriculum aims to provide an overview of the evidence for current and approved therapies for HCC spanning systemic targeted options and immune checkpoint inhibitors to provide community-based clinicians with the knowledge needed to be able to select and individualize therapy for their patients. Experts will offer insight into selecting and personalizing treatment for HCC in an increasingly complex therapeutic landscape, including best practice management for treatment-related side effects. Case-based scenarios will be utilized to illustrate key principles in treatment selection and disease management and an overview of current clinical trials will provide a look into the future in HCC.

Target Audience

This activity has been designed to meet the educational needs of medical oncologists, hepatologists, interventional radiologists, hepatobiliary surgeons, pathologists, radiologists, gastroenterologists, advanced practice oncology clinicians, nurses, and other clinicians involved in the care of patients with hepatocellular carcinoma.